Related Experiment Video
Updated: Aug 15, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
Mortality outcomes of various causes of syncope
Insights
Syncope in older applicants poses underwriting challenges. Unknown or vasovagal causes show increased mortality, with cardiac syncope indicating the highest risk, impacting insurance risk selection.
Area of Science:
- Cardiology
- Gerontology
- Epidemiology
Background:
- Syncope presents significant risk selection challenges in older individuals.
- Establishing a definitive cause for syncope is often difficult, complicating underwriting.
- Accurate mortality risk assessment is crucial for insurance medical directors.
Purpose of the Study:
- To analyze the mortality outcomes associated with various causes of syncope.
- To provide data for underwriting decisions concerning applicants with syncope of unknown etiology.
- To inform risk classification based on established syncope causes.
Main Methods:
- Analysis of mortality data from Framingham Heart Study participants over a 24-year period.
- Categorization of syncope causes including unknown, vasovagal, neurogenic, and cardiac.
- Calculation of mortality ratios and excess death rates for each syncope category.
Main Results:
- Syncope from vasovagal or other causes showed a 14% mortality ratio.
- Neurogenic syncope had a 168% mortality ratio; unknown cause syncope had a 192% mortality ratio.
- Cardiac syncope exhibited the highest mortality ratio at 270%, with no excess mortality for seizure-related syncope when excluded.
Conclusions:
- Syncope of unknown etiology or vasovagal origin is associated with increased mortality.
- Cardiac syncope represents a substantial mortality risk, requiring careful underwriting.
- These findings aid in actuarial assessments for insurance applicants with syncope.
Abstract:
Syncope, especially in older-age applicants, presents a risk selection quandary. When the etiology is established, risk classification is based on the causative impairment. However, often no diagnosis is ascertained. The lack of diagnosis presents a dilemma for the medical director. Underwriting decisions must be based on sound actuarial principles or related to actual and reasonable anticipated experience. The mortality outcome of various causes of syncope from participants of the Framingham Heart Study is presented in this abstract. The primary value to the medical director is the mortality outcome of those applicants without a specific etiologic diagnosis; those belonging to the unknown, the vasovagal or other causes groups. Over a 24-year observation period, patients whose syncope was attributed to vasovagal or other causes had a mortality ratio of 14% and an excess death rate of 20. Neurogenic syncope had a mortality ratio of 168% and an excess death rate of 34. No excess mortality was observed when those with seizures were excluded from analysis. Those whose cause of syncope was unknown had a mortality ratio of 192% and an excess death rate of 46. Individuals whose syncope was deemed to be cardiac exhibited a mortality ratio of 270% and an excess death rate of 82.
More Related Videos
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure III: Clinical Manifestations
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

